FXIII Mutation Detection Kit
£326.00
The Factor XIII (F13A1) V34L Variant Detection Kit is specifically designed to identify the V34L variant in the F13A1 gene, known for its protective role against venous thrombosis and its association with a reduced risk of stroke and myocardial infarction. Utilizing advanced multiplex RT-PCR technology, this kit facilitates the efficient detection of this beneficial genetic variation, supporting comprehensive assessments of cardiovascular and thrombotic disease risks.
- Ready to Reaction Mix: Simplifies the testing process, making it accessible and straightforward for laboratory use.
- Accurate Results: Comes with controls for both homozygous and heterozygous variants to ensure the reliability of the test outcomes.
- Dual Color Compatibility: Designed for compatibility with real-time PCR instruments capable of detecting FAM and VIC/HEX, allowing for the simultaneous detection of multiple genetic markers.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring the kit’s quality and reliability.
Genetic Risk Assessment for Thrombophilia and Cardiovascular Diseases: Aimed at detecting the F13A1 V34L variant, this kit is a vital tool for evaluating genetic predispositions to thrombophilia, venous thrombosis, stroke, and myocardial infarction.
- Technology: Uses multiplex RT-PCR for the targeted detection of the F13A1 V34L variant, among other genetic risk factors for thrombophilia.
- Compatibility: Compatible with FAM and VIC/HEX dual-color real-time PCR instruments.
- Controls Included: Features controls for both homozygous and heterozygous conditions to ensure testing accuracy.
- Certification: Carries the CE-IVD marking, indicating its approved use within the European Union for in vitro diagnostics.
- Ready to Reaction Mix: Simplifies the testing process, making it accessible and straightforward for laboratory use.
- Accurate Results: Comes with controls for both homozygous and heterozygous variants to ensure the reliability of the test outcomes.
- Dual Color Compatibility: Designed for compatibility with real-time PCR instruments capable of detecting FAM and VIC/HEX, allowing for the simultaneous detection of multiple genetic markers.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring the kit’s quality and reliability.
Genetic Risk Assessment for Thrombophilia and Cardiovascular Diseases: Aimed at detecting the F13A1 V34L variant, this kit is a vital tool for evaluating genetic predispositions to thrombophilia, venous thrombosis, stroke, and myocardial infarction.
- Technology: Uses multiplex RT-PCR for the targeted detection of the F13A1 V34L variant, among other genetic risk factors for thrombophilia.
- Compatibility: Compatible with FAM and VIC/HEX dual-color real-time PCR instruments.
- Controls Included: Features controls for both homozygous and heterozygous conditions to ensure testing accuracy.
- Certification: Carries the CE-IVD marking, indicating its approved use within the European Union for in vitro diagnostics.
Download essential technical information for this product.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
